BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1096779)

  • 1. Biochemical aspects of schizophrenia.
    Matthysse S; Lipinski J
    Annu Rev Med; 1975; 26():551-65. PubMed ID: 1096779
    [No Abstract]   [Full Text] [Related]  

  • 2. An enzyme (MAO) defect on the platelets in migraine.
    Sicuteri F; Buffoni F; Anselmi B; Del Bianco PL
    Res Clin Stud Headache; 1970; 3():245-51. PubMed ID: 5527206
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of neuroleptics on platelet monoamine oxidase activity.
    Ho BT; Smith RC; Kralik P; Allen R; Schoolar J; Khan M; DeJohn C
    Biol Psychiatry; 1982 Aug; 17(8):885-95. PubMed ID: 6126230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meeting report: Biochemical aspects of schizophrenia. Alabama, April 1975.
    Smythies JR; Bradley RJ; Linton PH
    Psychoneuroendocrinology; 1975; 1(2):199-201. PubMed ID: 1087034
    [No Abstract]   [Full Text] [Related]  

  • 5. Heterogeneity of human platelets. VII. Platelet monoamine oxidase activity in normals and patients with autoimmune thrombocytopenic purpura and reactive thrombocytosis: its relationship to platelet protein density.
    Friedhoff AJ; Miller JC; Karpatkin S
    Blood; 1978 Feb; 51(2):317-23. PubMed ID: 563748
    [No Abstract]   [Full Text] [Related]  

  • 6. Schizophrenia, a disorder of tryptophan metabolism.
    Gilka L
    Acta Psychiatr Scand Suppl; 1975; 258():1-83. PubMed ID: 1056684
    [No Abstract]   [Full Text] [Related]  

  • 7. Platelet monoamine oxidase and the growth hormone response to apomorphine in schizophrenia.
    Malas KL; van Kammen DP; deFraites EA; Brown GM; Gold PW
    Biol Psychiatry; 1983 Feb; 18(2):255-9. PubMed ID: 6830934
    [No Abstract]   [Full Text] [Related]  

  • 8. Platelet monoamine oxidase activity in schizophrenia.
    Psychopharmacol Bull; 1981 Jul; 17(3):26-31. PubMed ID: 6117103
    [No Abstract]   [Full Text] [Related]  

  • 9. Dopamine-beta-hydroxylase, monoamine oxidase, and schizophrenia.
    DeLisi LE; Wise CD; Potkin SG; Zalcman S; Phelps BH; Lovenberg W; Wyatt RJ
    Biol Psychiatry; 1980 Dec; 15(6):895-907. PubMed ID: 7459411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet monoamine oxidase activity and substrate preferences in schizophrenic patients.
    Meltzer HY; Stahl SM
    Res Commun Chem Pathol Pharmacol; 1974 Feb; 7(2):419-31. PubMed ID: 4594367
    [No Abstract]   [Full Text] [Related]  

  • 11. Metabolism and mentation.
    Williams RH
    J Clin Endocrinol Metab; 1970 Nov; 31(5):461-79. PubMed ID: 4394268
    [No Abstract]   [Full Text] [Related]  

  • 12. Platelet monoamine oxidase activity in neuroleptic-naive schizophrenic patients: lack of influence of chronic perphenazine treatment.
    Spivak B; Kosower N; Zipser Y; Shreiber-Schul N; Apter A; Tyano S; Weizman A
    Clin Neuropharmacol; 1994 Feb; 17(1):83-8. PubMed ID: 8149362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet monoamine oxidase activity in chronic schizophrenia.
    Trivedi JK; Tandon SK; Viswanathan PN; Gupta AK; Sethi BB
    Indian J Med Res; 1987 Jul; 86():79-83. PubMed ID: 3692563
    [No Abstract]   [Full Text] [Related]  

  • 14. Platelet enzyme abnormalities in neuropsychiatric disease.
    Farmer PM
    Ann Clin Lab Sci; 1980; 10(4):263-8. PubMed ID: 6108742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet monoamine oxidase in schizophrenia with beta-phenylethylamine and benzylamine as substrates.
    Baron M; Perumal AS; Levitt M; Cannova G
    Biol Psychiatry; 1982 Apr; 17(4):479-83. PubMed ID: 7082713
    [No Abstract]   [Full Text] [Related]  

  • 16. Prolactin levels in schizophrenia: relation to platelet monoamine oxidase, plasma amine oxidase, plasma dopamine-beta-hydroxylase, and erythrocyte catechol-O-methyltransferase activity.
    Baron M; Levitt M; Asnis L; Fein M
    Biol Psychiatry; 1983 May; 18(5):579-82. PubMed ID: 6860731
    [No Abstract]   [Full Text] [Related]  

  • 17. Platelet monoamine oxidase activity in anergic schizophrenics.
    Shaskan EG; Becker RE
    Psychopharmacol Bull; 1975 Jul; 11(3):39-40. PubMed ID: 1153659
    [No Abstract]   [Full Text] [Related]  

  • 18. [Etiology of schizophrenia: neurochemical aspects].
    de las Cuevas Castresana C; González de Rivera JL
    Neurologia; 1994 Feb; 9(2):54-9. PubMed ID: 7515627
    [No Abstract]   [Full Text] [Related]  

  • 19. Intracellular distribution of monoamine oxidase, 5-hydroxytryptamine and histamine in blood platelets of rabbit.
    Solatunturi E; Paasonen MK
    Ann Med Exp Biol Fenn; 1966; 44(3):427-30. PubMed ID: 5958861
    [No Abstract]   [Full Text] [Related]  

  • 20. Platelet monoamine-oxidase activity in schizophrenia. Relation to genetic load of the illness and treatment with antipsychotic drugs.
    Kemali D; Maj M; Ariano MG; Salvati A
    Encephale; 1985; 11(1):31-4. PubMed ID: 2859981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.